Corcept Therapeutics (CORT) Invested Capital: 2009-2025
Historic Invested Capital for Corcept Therapeutics (CORT) over the last 10 years, with Sep 2025 value amounting to $631.9 million.
- Corcept Therapeutics' Invested Capital fell 1.09% to $631.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $631.9 million, marking a year-over-year decrease of 1.09%. This contributed to the annual value of $679.6 million for FY2024, which is 34.12% up from last year.
- As of Q3 2025, Corcept Therapeutics' Invested Capital stood at $631.9 million, which was down 0.61% from $635.8 million recorded in Q2 2025.
- In the past 5 years, Corcept Therapeutics' Invested Capital ranged from a high of $683.3 million in Q1 2025 and a low of $375.8 million during Q4 2021.
- Its 3-year average for Invested Capital is $575.7 million, with a median of $596.2 million in 2024.
- In the last 5 years, Corcept Therapeutics' Invested Capital fell by 28.19% in 2021 and then spiked by 41.42% in 2024.
- Quarterly analysis of 5 years shows Corcept Therapeutics' Invested Capital stood at $375.8 million in 2021, then skyrocketed by 33.54% to $501.8 million in 2022, then rose by 0.97% to $506.7 million in 2023, then skyrocketed by 34.12% to $679.6 million in 2024, then dropped by 1.09% to $631.9 million in 2025.
- Its last three reported values are $631.9 million in Q3 2025, $635.8 million for Q2 2025, and $683.3 million during Q1 2025.